ImmuPharma PLC
  • Announcements
  • About Us
    • About Us
    • Our Team
    • Board of Directors
  • Our Science
    • Our Science
    • ImmuPharma Biotech
    • Key Clinical Investigators
  • Pipeline
    • Pipeline
    • Autoimmunity & Inflammation
    • Anti-Infectives
  • Partnerships & Collaborations
  • Investors
    • Investors
    • AIM Rule 26 Information
    • Regulatory News
    • Corporate Governance
    • Board of Directors
    • Annual Reports
    • Analyst Research
    • Interviews
    • Professional advisers
    • Email Alerts
  • Contact
Archives
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
July 29, 2015

Richard Warr

Read More
July 27, 2015

ClinicalTrials.Gov registration of LUPUZOR™ Pivotal Phase III Trial

Read More
July 25, 2015

Term Sheet signed with US Investor to secure up to US$14 Million Funding For LUPUZOR™

Read More
June 25, 2015

Lupuzor’s Founder, Dr Slyviane Muller – Awarded Medal of Innovation from CNRS for Lupuzor™

Read More
May 29, 2015

ANNUAL GENERAL MEETING: 2015

Read More
May 07, 2015

Notice of Annual General Meeting: 29 May 2015

Read More
April 30, 2015

Preliminary Results Announcement for the year ended 31 December 2014

Read More
April 30, 2015

Dr Stéphane Méry Appointed as Non-Executive Director

Read More
February 11, 2015

Cancer Update: IPP-204106

Read More
January 27, 2015

Advance Assurance Received from H M Revenue and Customs Regarding “Enterprise Investment Scheme” Status

Read More
January 22, 2015

Landmark Collaboration Agreement & Commencement of Pivotal Phase III Lupuzor™ Study with Simbec-Orion

Read More
October 21, 2014

ImmuPharma awarded €400,000 grant in support of its pioneering research in the Bordeaux region of France

Read More
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Keep up-to-date with email alerts

  • @immupharma

Aim Rule 26 Contact informationDisclaimerPrivacy PolicySite map

© ImmuPharma PLC 2005-2022 | All rights reserved